Business Wire

Yokogawa Announces Synaptic Business Automation(TM) Concept for Industrial Automation and Control Business


Yokogawa Electric Corporation (TOKYO:6841) announces Synaptic Business Automation(TM), a new industrial automation and control business concept that expresses the company’s commitment to working with its customers to sustain their creation of corporate value. Based on the ideals expressed in the Synaptic Business Automation concept, Yokogawa will help companies achieve a transformation in how they conduct their business.

This press release features multimedia. View the full release here:

Creation of value through Synaptic Business Automation for profitable and sustainable growth (Graphi ...

Creation of value through Synaptic Business Automation for profitable and sustainable growth (Graphic: Yokogawa Electric Corporation)

A Closer Look at Synaptic Business Automation
Manufacturers face a variety of challenges today, ranging from volatile shifts in the prices of crude oil and other raw materials and stiffening environmental and safety regulations to structural changes in their industries. To remain competitive, they must have the agility to adapt quickly to change.

To guide its efforts to assist companies in meeting such challenges, Yokogawa adheres to a vision statement that reads, “Through ‘Process Co-Innovation,’ Yokogawa creates new value with its clients for a brighter future.” We help companies improve efficiency and profitability by getting their various business units to work together more effectively and by eliminating barriers that impede the flow of information and goods throughout the supply chain and between companies.

As the Internet of Things gains traction, a digitalization of processes is underway whereby the use of big data and artificial intelligence is yielding valuable insights needed to make business decisions. The Synaptic Business Automation concept clearly expresses Yokogawa’s commitment to using the latest information technologies and its decades of experience with plant management and industrial processes, portfolio of automation solutions, and consulting expertise to help its customers transform their businesses.

The Synaptic Business Automation concept takes its name from the synapse, a structure in the nervous system that plays a role in the transfer of signals to other parts of the human body. Synaptic Business Automation expresses an ideal state for a business whereby the synthesizing of data, systems, organizations, knowledge, and supply chains adds value and strengthens competitiveness. The linked data on manufacturing processes, plant operations, human resources, and supply chains can be organized, integrated, controlled, broken down, and analyzed to yield insightful decisions at various levels in the organization, from operations in the field to corporate management.

Ways in which Synaptic Business Automation creates corporate value for our customers:

  1. Resilient operation
    Adapt more flexibly to changes in such areas as health, safety, security and the environment (HSSE), organizational optimization, and regulatory compliance.
  2. Optimized production
    Optimize the total expenditure (TOTEX) components of capital expenditure (CAPEX) and operational expenditure (OPEX) over the entire lifecycle of a plant, and improve reliability. Also, directly create value by solving issues and optimizing operations throughout a supply chain, thereby enhancing productivity and profitability.
  3. Business innovation
    Work with specific customers to create new business models that foster manufacturing excellence by such means as supplying cloud-based services that drive collaboration with their customers and suppliers and to introduce environmentally friendly manufacturing practices that are essential for a sustainable society.

Yokogawa has many years of experience in working with operational technology (OT). By combining its in-depth knowledge of plant management, operations, industries, and processes, its portfolio of automation and other information technology solutions, and its consulting expertise, the company is uniquely positioned to create new value. Working together with its customers based on the Co-innovating tomorrow (R) corporate brand slogan, Yokogawa is committed to helping them achieve the ideals expressed in its Synaptic Business Automation concept.

For more information

About Yokogawa
Yokogawa's global network of 113 companies spans 60 countries. Founded in 1915, the US$3.5 billion company engages in cutting-edge research and innovation. Yokogawa is active in the industrial automation and control (IA), test and measurement, and aviation and other businesses segments. The IA segment plays a vital role in a wide range of industries including oil, chemicals, natural gas, power, iron and steel, pulp and paper, pharmaceuticals, and food. Targeting this segment, Yokogawa helps companies maximize their profits by offering a wide range of highly reliable products and working with the subsidiary KBC Advanced Technologies to provide premium solutions and services. For more information about Yokogawa, please visit

The names of corporations, organizations, and products herein are either trademarks or registered trademarks of their respective holders.

Contact information

Yokogawa Electric Corporation
Public Relations, Integrated Communications Center

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 21:28Tiedote

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 19:05Tiedote

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 15:52Tiedote

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 15:50Tiedote

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 15:46Tiedote

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 15:00Tiedote

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme